BE692082A - - Google Patents

Info

Publication number
BE692082A
BE692082A BE692082DA BE692082A BE 692082 A BE692082 A BE 692082A BE 692082D A BE692082D A BE 692082DA BE 692082 A BE692082 A BE 692082A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE692082A publication Critical patent/BE692082A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE692082D 1966-01-03 1967-01-03 BE692082A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US517995A US3360518A (en) 1966-01-03 1966-01-03 Tetrahydro-halo-sulfamyl quinazolinones

Publications (1)

Publication Number Publication Date
BE692082A true BE692082A (he) 1967-06-16

Family

ID=24062092

Family Applications (1)

Application Number Title Priority Date Filing Date
BE692082D BE692082A (he) 1966-01-03 1967-01-03

Country Status (14)

Country Link
US (1) US3360518A (he)
AT (2) AT286989B (he)
BE (1) BE692082A (he)
BR (1) BR6785894D0 (he)
CH (1) CH515910A (he)
DE (1) DE1620740C3 (he)
DK (1) DK134113B (he)
ES (1) ES334560A1 (he)
FI (1) FI51350C (he)
FR (1) FR6844M (he)
GB (1) GB1170790A (he)
IL (1) IL27126A (he)
NL (1) NL149493B (he)
SE (1) SE390969B (he)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452019A (en) * 1967-11-16 1969-06-24 Wallace & Tiernan Inc 1-phenylalkyl-tetrahydro-halo-sulfamyl-quinazolinone
US3452020A (en) * 1967-11-09 1969-06-24 Wallace & Tiernan Inc 2-alkenyl and 2-alkynyl substituted - tetrahydro - halo-sulfamyl-quinazolinones
US3458513A (en) * 1967-11-02 1969-07-29 Wallace & Tiernan Inc 2-substituted-tetrahydro-halosulfamyl-quinazolinones

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518267A (en) * 1968-02-23 1970-06-30 Pennwalt Corp 1-aminoalkyl and 1-hydroxyalkyl-tetrahydro-halo-sulfamyl-quinazolinone
US3549636A (en) * 1968-02-29 1970-12-22 Pennwalt Corp 2-alkanoyl,alkanoylalkyl,alkanoyloxyalkyl,and hydroxyalkyl substituted tetrahydro - halo - sulfamyl- quinazolinones
US3549629A (en) * 1968-02-29 1970-12-22 Pennwalt Corp 2 - substituted or unsubstituted carboxy tetrahydro - halo - sulfamyl-quinazolinones
US3549634A (en) * 1968-03-28 1970-12-22 Pennwalt Corp 8,5 - amino - substituted - tetrahydrohalo-sulfamyl-quinazolinones
US3541096A (en) * 1968-12-24 1970-11-17 Pennwalt Corp 2-aryl-substituted-tetrahydro-halo-sulfamyl-quinazolinones
ZA732937B (en) * 1972-05-05 1974-03-27 Maggioni & C Spa Non mercurial diuretics
EP0057763A1 (en) * 1981-01-26 1982-08-18 Pennwalt Corporation Improved process for the preparation of 2-methyl-3-(o-tolyl)-7-chloro-1,2,3,4-tetrahydro-4-oxo-6-quinazolinesulfonamide
US4522818A (en) * 1982-10-14 1985-06-11 Pennwalt Corporation Diuretic/antihypertensive compositions
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US5264439A (en) * 1990-02-13 1993-11-23 Merck & Co., Inc. Quinazolinone, triazolinone and pyrimidinone angiotensin II antagonists incorporating a substituted benzyl element
US5633240A (en) * 1994-09-01 1997-05-27 Academic Pharmaceuticals Parenteral solutions containing metolazone
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
KR100656716B1 (ko) * 2000-11-21 2006-12-13 상꾜 가부시키가이샤 의약 조성물
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
JP2008520578A (ja) * 2004-11-15 2008-06-19 ニトロメッド インコーポレーティッド 複素環式の酸化窒素供与体基を含む利尿化合物、組成物および使用方法
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
ES2847904T3 (es) 2013-07-23 2021-08-04 Daiichi Sankyo Co Ltd Medicamento para la prevención o el tratamiento de la hipertensión
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976289A (en) * 1961-03-21 X-tetrahydro -
GB1464445A (en) * 1973-02-19 1977-02-16 Mitsubishi Electric Corp Apparatus for making a printing master
DE3266655D1 (en) * 1982-06-04 1985-11-07 Hell Rudolf Dr Ing Gmbh Process to avoid image defects in multicolour printing caused by non coincident printing of the colour separations
GB8410860D0 (en) * 1984-04-27 1984-06-06 Crosfield Electronics Ltd Image modification

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458513A (en) * 1967-11-02 1969-07-29 Wallace & Tiernan Inc 2-substituted-tetrahydro-halosulfamyl-quinazolinones
US3452020A (en) * 1967-11-09 1969-06-24 Wallace & Tiernan Inc 2-alkenyl and 2-alkynyl substituted - tetrahydro - halo-sulfamyl-quinazolinones
US3452019A (en) * 1967-11-16 1969-06-24 Wallace & Tiernan Inc 1-phenylalkyl-tetrahydro-halo-sulfamyl-quinazolinone

Also Published As

Publication number Publication date
BR6785894D0 (pt) 1973-12-27
DE1620740A1 (de) 1970-05-21
NL149493B (nl) 1976-05-17
GB1170790A (en) 1969-11-19
US3360518A (en) 1967-12-26
DK134113C (he) 1977-02-14
FR6844M (he) 1969-04-08
NL6700083A (he) 1967-07-04
FI51350B (he) 1976-08-31
DE1620740B2 (de) 1978-09-14
DK134113B (da) 1976-09-13
SE390969B (sv) 1977-01-31
FI51350C (fi) 1976-12-10
AT291269B (de) 1971-07-12
DE1620740C3 (de) 1979-05-10
ES334560A1 (es) 1967-11-01
IL27126A (he) 1972-01-27
AT286989B (de) 1971-01-11
CH515910A (de) 1971-11-30

Similar Documents

Publication Publication Date Title
AU5917865A (he)
AU428063B2 (he)
AU424443B2 (he)
AU414526B2 (he)
AU433222B2 (he)
AU421822B2 (he)
AU417216B2 (he)
AU415165B1 (he)
AU6703465A (he)
AU612166A (he)
AU5895065A (he)
AU1111066A (he)
AU218666A (he)
BE284991A (he)
BE618801A (he)
AU2390066A (he)
AU433620A (he)
AU415780B2 (he)
AU414093B2 (he)
AU407778B2 (he)
BE676616A (he)
AU411645B2 (he)
AU6852465A (he)
AU855865A (he)
AU92366A (he)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: PENNWALT CORP.

Effective date: 19870103